#1 Reflects the weighted average purchase price. The range of prices for such transaction is $7.255 to $7.27. Open market purchase transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within the price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

#1 Represents the forfeiture as a result of the Transition and Separation Agreement dated May 31, 2024 between the Company and the reporting person ("Agreement") of (i) 3,917 restricted stock units granted pursuant to the PetMed Express, Inc.'s 2022 Employee Equity Compensation Plan ("2022 Plan") on June 15, 2023, and (ii) 37,425 restricted stock units granted pursuant to the 2022 Plan on May 16, 2024.

#1 Represents the forfeiture of performance-based restricted performance stock granted to the reporting person on August 3, 2022, the restrictions for which shares were eligible to lapse based on the attainment of certain financial performance objectives. Upon grant, the target amount of shares was reported in Table I of the reporting person's Form 3. On June 8, 2023, the Company determined that, based on the Company's performance over the applicable performance period, the 3,000 restricted performance shares would be forfeited.

#1 Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2022 Employee Equity Compensation Plan. Twenty percent of the RSUs vest on June 30, 2024, thirty percent vest on August 31, 2024, and fifty percent vest on August 31, 2025, all subject to continued employment with the Company through the applicable vesting date (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.